Clinical trial

Blood Microbiota Signature of Alzheimer's Disease

NCT04841135

Study summary

ClinicalTrials.gov

Blood Microbiota Signature of Alzheimer's Disease

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Multiomics quantification Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Polysomnography Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-06-03

PhaseNA

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Elderly With Normal Cognitionunresolved

Interventions

Multiomics quantificationOTHER

PolysomnographyOTHER

Sponsors & collaborators

University Hospital, Montpellierlead sponsor

Mapped research locations

MontpellierFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04841135 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.